OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization
Tzu-Ping Chien, Song-Fong Huang, Wen‐Hui Chan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Tzu-Ping Chien, Song-Fong Huang, Wen‐Hui Chan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Showing 13 citing articles:
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Jing Long, Xin Zhang, Wei Mi, et al.
Aging (2024)
Open Access | Times Cited: 4
Jing Long, Xin Zhang, Wei Mi, et al.
Aging (2024)
Open Access | Times Cited: 4
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis
Xuanmei Li, Xue Huang, Lifu Lei, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 6
Xuanmei Li, Xue Huang, Lifu Lei, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 6
Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis
Anrong Wang, Junfeng Li, Changfeng Li, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25237-e25237
Open Access | Times Cited: 1
Anrong Wang, Junfeng Li, Changfeng Li, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25237-e25237
Open Access | Times Cited: 1
Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk
Giorgio Esposto, Raffaele Borriello, Linda Galasso, et al.
Diagnostics (2024) Vol. 14, Iss. 4, pp. 371-371
Open Access | Times Cited: 1
Giorgio Esposto, Raffaele Borriello, Linda Galasso, et al.
Diagnostics (2024) Vol. 14, Iss. 4, pp. 371-371
Open Access | Times Cited: 1
Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II HCC undergoing surgery? An observational cohort study
Chao‐Wei Lee, Hsin‐I Tsai, Hsiao-Mei Hsu, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7067-7079
Open Access | Times Cited: 1
Chao‐Wei Lee, Hsin‐I Tsai, Hsiao-Mei Hsu, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 11, pp. 7067-7079
Open Access | Times Cited: 1
Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy
Kyoko Oura, Asahiro Morishita, Joji Tani, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1834-1834
Open Access | Times Cited: 3
Kyoko Oura, Asahiro Morishita, Joji Tani, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1834-1834
Open Access | Times Cited: 3
AI-derived body composition parameters as prognostic factors in patients with HCC undergoing TACE in a multicenter study
Lukáš Müller, Aline Mähringer‐Kunz, Timo Alexander Auer, et al.
JHEP Reports (2024) Vol. 6, Iss. 8, pp. 101125-101125
Open Access
Lukáš Müller, Aline Mähringer‐Kunz, Timo Alexander Auer, et al.
JHEP Reports (2024) Vol. 6, Iss. 8, pp. 101125-101125
Open Access
Causal association of sarcopenia with hepatocellular carcinoma risk in European population: a Mendelian randomization study
Jiali Cao, Yumei Huang, Mengpei Zhu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Jiali Cao, Yumei Huang, Mengpei Zhu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Serum interferon-gamma-induced protein 10 levels can help predict sarcopenia development in patients with primary hepatocellular carcinoma: A retrospective cohort study
Hitomi Takada, Leona Osawa, Yasuyuki Komiyama, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hitomi Takada, Leona Osawa, Yasuyuki Komiyama, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis
Yen‐Chun Chen, Meng‐Hsuan Kuo, Ching‐Sheng Hsu, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 319-319
Open Access
Yen‐Chun Chen, Meng‐Hsuan Kuo, Ching‐Sheng Hsu, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 319-319
Open Access
The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2315-2315
Open Access
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2315-2315
Open Access
Effect of sarcopenia and albumin-bilirubin grade on survival in patients with hepatocellular carcinoma under transarterial chemoembolization
Xiaojuan Wang, Jinlong Li, Jitao Wang, et al.
Research Square (Research Square) (2023)
Open Access
Xiaojuan Wang, Jinlong Li, Jitao Wang, et al.
Research Square (Research Square) (2023)
Open Access
Elevated serum IP-10/CXCL10 levels are associated with sarcopenia development, a prognostic factor, in patients with primary hepatocellular carcinoma
Hitomi Takada, Koji Yamashita, Leona Osawa, et al.
Research Square (Research Square) (2023)
Open Access
Hitomi Takada, Koji Yamashita, Leona Osawa, et al.
Research Square (Research Square) (2023)
Open Access
